[{"address1": "99 High Street", "address2": "30th Floor", "city": "Boston", "state": "MA", "zip": "02110", "country": "United States", "phone": "617 300 8460", "website": "https://praxismedicines.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase III clinical trial for the treatment of essential tremor; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc.; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc.; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts.", "fullTimeEmployees": 82, "companyOfficers": [{"maxAge": 1, "name": "Mr. Marcio Silva De'Souza M.B.A.", "age": 44, "title": "President, CEO & Director", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 1179148, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy Edwin Kelly", "age": 51, "title": "CFO & Treasurer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 691583, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Nemiroff J.D.", "age": 44, "title": "General Counsel & Secretary", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 577338, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven  Petrou B.Sc. (Hons.), Ph.D.", "title": "Co-Founder & Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lauren  Mastrocola", "title": "VP of Finance & Principal Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karl  Hansen Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Kane", "title": "VP of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  McCue", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alyssa J. S. Wyant", "age": 49, "title": "Chief Regulatory & Quality Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan T. Sniecinski", "age": 42, "title": "Chief Business Officer", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 65.03, "open": 39.95, "dayLow": 37.6001, "dayHigh": 42.55, "regularMarketPreviousClose": 65.03, "regularMarketOpen": 39.95, "regularMarketDayLow": 37.6001, "regularMarketDayHigh": 42.55, "payoutRatio": 0.0, "beta": 2.668, "forwardPE": -3.5380385, "volume": 3197393, "regularMarketVolume": 3197393, "averageVolume": 414278, "averageVolume10days": 712430, "averageDailyVolume10Day": 712430, "bid": 38.08, "ask": 39.15, "bidSize": 8, "askSize": 4, "marketCap": 719419072, "fiftyTwoWeekLow": 33.01, "fiftyTwoWeekHigh": 91.83, "priceToSalesTrailing12Months": 448.23618, "fiftyDayAverage": 75.7404, "twoHundredDayAverage": 62.2695, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 856642624, "profitMargins": 0.0, "floatShares": 14713966, "sharesOutstanding": 18637800, "sharesShort": 2668966, "sharesShortPriorMonth": 2040384, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.1432, "heldPercentInsiders": 0.0049799997, "heldPercentInstitutions": 1.17625, "shortRatio": 6.89, "shortPercentOfFloat": 0.1434, "impliedSharesOutstanding": 18637800, "bookValue": 21.515, "priceToBook": 1.7940971, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -151018000, "trailingEps": -9.17, "forwardEps": -10.91, "lastSplitFactor": "1:15", "lastSplitDate": 1701216000, "enterpriseToRevenue": 533.734, "enterpriseToEbitda": -5.236, "52WeekChange": -0.29446173, "SandP52WeekChange": 0.16050637, "quoteType": "EQUITY", "currentPrice": 38.6, "targetHighPrice": 305.0, "targetLowPrice": 97.0, "targetMeanPrice": 162.9, "targetMedianPrice": 135.0, "recommendationMean": 1.63636, "recommendationKey": "buy", "numberOfAnalystOpinions": 10, "totalCash": 357032000, "totalCashPerShare": 19.156, "ebitda": -163592992, "totalDebt": 1660000, "quickRatio": 10.865, "currentRatio": 10.957, "totalRevenue": 1605000, "debtToEquity": 0.434, "revenuePerShare": 0.106, "returnOnAssets": -0.39202, "returnOnEquity": -0.64342004, "grossProfits": -112908000, "freeCashflow": -48460376, "operatingCashflow": -99496000, "revenueGrowth": -0.355, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -188.19536, "financialCurrency": "USD", "symbol": "PRAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "exchange": "NMS", "messageBoardId": "finmb_409236524", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -40.64278, "regularMarketPrice": 38.6, "corporateActions": [], "postMarketTime": 1740790362, "regularMarketTime": 1740776401, "hasPrePostMarketData": true, "shortName": "Praxis Precision Medicines, Inc", "longName": "Praxis Precision Medicines, Inc.", "cryptoTradeable": false, "firstTradeDateMilliseconds": 1602855000000, "postMarketChangePercent": 1.26943, "postMarketPrice": 39.09, "postMarketChange": 0.490002, "regularMarketChange": -26.43, "regularMarketDayRange": "37.6001 - 42.55", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 414278, "fiftyTwoWeekLowChange": 5.59, "fiftyTwoWeekLowChangePercent": 0.16934264, "fiftyTwoWeekRange": "33.01 - 91.83", "fiftyTwoWeekHighChange": -53.230003, "fiftyTwoWeekHighChangePercent": -0.5796581, "fiftyTwoWeekChangePercent": -29.446173, "earningsTimestamp": 1740747600, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "earningsCallTimestampStart": 1730898000, "earningsCallTimestampEnd": 1730898000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -9.17, "epsForward": -10.91, "epsCurrentYear": -12.06093, "priceEpsCurrentYear": -3.2004163, "fiftyDayAverageChange": -37.140404, "fiftyDayAverageChangePercent": -0.4903645, "twoHundredDayAverageChange": -23.669502, "twoHundredDayAverageChangePercent": -0.3801139, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-16", "averageAnalystRating": "1.6 - Buy", "displayName": "Praxis Precision Medicines", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]